TCIM
INFI

TIAA CREF Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

TIAA CREF Investment Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-213,942
Closed -$691K – 3195
2017
Q1 		$691K Sell
213,942
-51,616
-19% -$127K ﹤0.01% 2681
2016
Q4 		$359K Buy
265,558
+14,679
+6% +$19.2K ﹤0.01% 2932
2016
Q3 		$391 Buy
250,879
+72,143
+40% +$111K ﹤0.01% 2941
2016
Q2 		$238K Buy
178,736
+22,872
+15% +$107K ﹤0.01% 3071
2016
Q1 		$821K Sell
155,864
-90,650
-37% -$555K ﹤0.01% 2593
2015
Q4 		$1.94M Sell
246,514
-112,690
-31% -$970K ﹤0.01% 2175
2015
Q3 		$3.04M Sell
359,204
-13,332
-4% -$123K ﹤0.01% 1887
2015
Q2 		$4.08M Buy
372,536
+19,903
+6% +$255K ﹤0.01% 1827
2015
Q1 		$4.93M Buy
352,633
+107,076
+44% +$1.64M ﹤0.01% 1640
2014
Q4 		$4.15M Buy
245,557
+66,224
+37% +$964K ﹤0.01% 1754
2014
Q3 		$2.41M Sell
179,333
-5,232
-3% -$62.3K ﹤0.01% 2106
2014
Q2 		$2.35M Sell
184,565
-993
-0.5% -$10.3K ﹤0.01% 2210
2014
Q1 		$2.21M Sell
185,558
-2,240
-1% -$30.1K ﹤0.01% 2183
2013
Q4 		$2.59M Sell
187,798
-3,928
-2% -$55.5K ﹤0.01% 2095
2013
Q3 		$3.35M Sell
191,726
-3,137
-2% -$60.1K ﹤0.01% 1875
2013
Q2 		$3.17M Buy
+194,863
New +$6.03M ﹤0.01% 1858

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

TIAA CREF Investment Management's INFI Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 213,942 shares — an estimated $691K sold.

TIAA CREF Investment Management first reported a position in INFI in Q2 2013 and held it in 16 quarters. The position peaked at $4.93M in Q1 2015. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 213,942 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $691K.
  • TIAA CREF Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
  • TIAA CREF Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $4.93M in Q1 2015.
  • 74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.